Product Program year 2020 Source: CMS Open Payments

Precision Infusion System

Device Oncology

Open in the dashboard

General payments

$953,481

565 payments

Research payments

$300,352

22 payments

Through program year 2020, $953,481 in general payments and $300,352 in research payments were reported against Precision Infusion System (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $254,517 269
2020 Research $176,657 18
2019 General $698,965 296
2019 Research $123,695 4

Breakdown

Who paid General payments · program years 2019–2020
  1. Surefire Medical, Inc. $953,481 565 payments
Top recipients General payments · program year 2020
  1. Steven Katz Surgical Oncology · Providence, RI $134,975 53% · 30 payments
  2. Aravind Arepally Vascular & Interventional Radiology · Atlanta, GA $30,033 12% · 11 payments
  3. Dennis Griffin Diagnostic Radiology · Englewood, CO $27,305 11% · 39 payments
  4. David Porter Diagnostic Radiology · Greenwood Village, CO $16,399 6% · 25 payments
  5. Richard Carvajal Medical Oncology · New York, NY $16,200 6% · 3 payments

The top 5 of 97 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Surgical Oncology Surgery $134,975 53% · 1 practitioner
  2. Diagnostic Radiology Radiology $67,728 27% · 26 practitioners
  3. Vascular & Interventional Radiology Radiology $34,788 14% · 63 practitioners
  4. Medical Oncology Internal Medicine $16,622 7% · 2 practitioners
  5. Surgery $115 <1% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Rhode Island $135,118 53% · 2 recipients
  2. Colorado $59,722 23% · 18 recipients
  3. Georgia $30,299 12% · 10 recipients
  4. New York $16,760 7% · 6 recipients
  5. Ohio $7,595 3% · 4 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

565 general · 22 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record